SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041429
Filing Date
2023-08-10
Accepted
2023-08-10 16:39:44
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tpst-20230630.htm   iXBRL 10-Q 2309608
2 EX-10.1 tpst-ex10_1.htm EX-10.1 360995
3 EX-10.2 tpst-ex10_2.htm EX-10.2 100603
4 EX-10.3 tpst-ex10_3.htm EX-10.3 332525
5 EX-10.4 tpst-ex10_4.htm EX-10.4 136483
6 EX-31.1 tpst-ex31_1.htm EX-31.1 23931
7 EX-31.2 tpst-ex31_2.htm EX-31.2 23849
8 EX-32.1 tpst-ex32_1.htm EX-32.1 11361
  Complete submission text file 0000950170-23-041429.txt   8171954

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tpst-20230630_lab.xml EX-101.LAB 361416
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpst-20230630_def.xml EX-101.DEF 131373
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpst-20230630_pre.xml EX-101.PRE 254561
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpst-20230630_cal.xml EX-101.CAL 37838
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpst-20230630.xsd EX-101.SCH 38844
55 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20230630_htm.xml XML 1113574
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 231160209
SIC: 2834 Pharmaceutical Preparations